Skip to content

Virtual Reality-Based Mindfulness for Caregivers of Psychiatric Patients

Mental Health Treatment in Caregivers of Psychiatric Patients: Application of Virtual Reality-Mediated Mindfulness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07387562
Enrollment
46
Registered
2026-02-04
Start date
2025-09-01
Completion date
2026-12-01
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caregivers, Caregivers Burnout

Keywords

caregivers, vr, virtual reality, mindfulness

Brief summary

This clinical investigation aims to compare the mental health status of caregivers of psychiatric patients before and after virtual reality-based mindfulness. The study's primary objectives are to: 1. Does immersive audio-based mindfulness have a greater positive impact on psychological well-being than virtual reality-mediated mindfulness? 2. When compared to a single session, do four sessions lead to more improvements in psychological well-being? To assess the additional impact of virtual reality-mediated mindfulness, participants in the control group will receive mindfulness via immersive audio. Those who voluntarily sign up for the study will participate in four sessions, one each week, on the same day and at the same time. Prior to and following the mindfulness intervention, self-administered psychometric assessment batteries will be completed. While the control group will use ears to complete the mindfulness session using immersive audio, the experimental group will get a virtual reality-mediated mindfulness intervention. BECOME is the company that provides the audio and video content.

Detailed description

In a sample of caregivers who visit the Department of Psychiatry at the "Renato Dulbecco" University Hospital in Catanzaro, the effects of the combined VR plus immersive audio treatment will be compared with the effects of immersive audio stimulation alone using a randomized controlled trial (RCT) design. The main goal is to evaluate how much the experimental group's caregivers' mental health has improved both before and after therapy. The following self-report measures will be used for assessment: The World Health Organization Well-Being Index (WHO-5), the Zarit Burden Interview (ZBI), the Perceived Stress Scale (PSS-10), the Italian Mental Health Continuum-Short Form (MHC-SF), the Scale of Positive and Negative Experiences (SPANE), the Beck Depression Inventory-II (BDI-II), the State-Trait Anxiety Inventory (STAI), and the Pittsburgh Sleep Quality Index (PSQI). Assessing variations in treatment effectiveness between the experimental and control groups is the secondary goal.

Interventions

Using the Meta Quest Pro headset, participants will participate in four virtual reality mindfulness exercises designed to improve relaxation and body awareness. Become's proprietary system (https://discoverbecome.com/) will be used for the sessions. The following is how the immersive "Augmented Wellbeing" sessions will be organized: 1. observing the situation in "The Secret Garden"; 2. observing the "Sunset Beach" situation; 3. observing the "Waterfall in the Meadow" situation; Reviewing the earlier sessions after viewing a scenario chosen by the participants to encourage self-determination and involvement.

DEVICEAudio immersivo

In order to improve body awareness and relaxation, participants will participate in four audio-only mindfulness sessions (immersive mindfulness audio). The same firm, BECOME, provides the audio track, which is the same as the one used in the VR immersive sessions. The number and length of sessions completed by participants will be identical to those of the experimental group, and the sessions will follow the same format: 1. "The Secret Garden" immersive audio; 2. "Sunset Beach" immersive audio; 3. "Waterfall in the Meadow" immersive audio; Audio chosen by the participants to encourage participation and self-determination, followed by a recap of the earlier sessions.

Sponsors

Istituto per la Ricerca e l'Innovazione Biomedica
Lead SponsorOTHER
Azienda Ospedaliero Universitaria Renato Dulbecco di Catanzaro
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years. * Being the primary caregiver of a psychiatric patient with a clinically confirmed diagnosis for at least 6 months. * Willingness to participate for the entire duration of the study. * Signed informed consent.

Exclusion criteria

* Active psychiatric diagnosis in the acute phase. * Previous regular use of mindfulness techniques or other relaxation techniques at any point in life. * Current use of psychotropic medications by the caregiver. * Photosensitive epilepsy (due to VR headset use). * Severe cognitive or sensory impairment. * Binocular vision abnormalities. * Hearing aids.

Design outcomes

Primary

MeasureTime frame
State-Trait Anxiety Inventory (STAI)From enrollment to the end of treatment at 4 weeks
Beck Depression Inventory (BDI-II)From enrollment to the end of treatment at 4 weeks
Italian Mental Health Continuum - Short Form (MHC-SF)From enrollment to the end of treatment at 4 weeks
Perceived Stress Scale (PSS-10)From enrollment to the end of treatment at 4 weeks
WHO-5From enrollment to the end of treatment at 4 weeks
Mindful Attention Awareness Scale (MAAS)From enrollment to the end of treatment at 4 weeks
Zarit Burden Interview (ZBI)From enrollment to the end of treatment at 4 weeks
Scale of Positive and Negative Experiences (SPANE)From enrollment to the end of treatment at 4 weeks

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026